株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のがん診断市場:北米、欧州、アジア太平洋地域、ラテンアメリカ、アフリカ、中東 - 売上高の予測と戦略、サプライヤーシェア - 新興の腫瘍市場、技術、機会

2020 World Tumor Markers Sales Segment Forecasts: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities

発行 Venture Planning Group 商品コード 427259
出版日 ページ情報 英文 1450 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。

Local License: 同一事業所内

世界のがん診断市場:北米、欧州、アジア太平洋地域、ラテンアメリカ、アフリカ、中東 - 売上高の予測と戦略、サプライヤーシェア - 新興の腫瘍市場、技術、機会 2020 World Tumor Markers Sales Segment Forecasts: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities
出版日: ページ情報: 英文 1450 Pages
概要

当レポートでは、世界のがん診断市場について調査分析し、腫瘍マーカーの市場セグメント分析と予測、既存/新興のサプライヤー、既存/新興の診断検査、既存の検査装置、新興の技術、固有の機会や成長戦略について、体系的な情報を提供しています。

第1章 イントロダクション

第2章 世界市場の概要

第3章 主な製品開発の機会

  • 試薬キットと検査システム/パネル
  • 検査装置
  • コンピューター、ソフトウェア、オートメーション
  • 補助製品

第4章 分散型検査製品の設計基準

第5章 代替的な市場浸透戦略

  • 自社開発
  • 共同開発
  • 大学との提携
  • 流通戦略

第6章 潜在的な市場参入障壁とリスク

  • 市場の成熟
  • コスト抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

第7章 世界市場と技術の概要

  • がんの統計と病因
    • 乳がん
    • 肺がん
    • 結腸・直腸がん
    • 前立腺がん
    • 胃がん
    • 白血病
    • リンパ腫
    • 口腔がん
    • 皮膚がん
    • 子宮がん
    • 卵巣がん
    • 膀胱がん
  • 既存/新興のがん診断検査 (全33種)
  • 検査装置レビューと市場ニーズ
  • 既存/新興の技術
    • モノクローナル/ポリクローナル抗体
    • イムノアッセイ (免疫測定法)
    • 染色体分析
    • 人工知能
    • フローサイトメトリー
    • 2次元ゲル電気泳動
    • バイオセンサー
    • 競合/補完技術
  • 個人向け検査

第8章 国別市場分析:検査件数と売上高の予測、サプライヤーシェア

  • アルゼンチン
  • オーストラリア
  • オーストリア
  • バーレーン
  • バングラデシュ
  • ベルギー
  • ブラジル
  • ブルガリア
  • カナダ
  • チリ
  • 中国
  • コロンビア
  • クロアチア
  • キプロス
  • チェコ共和国
  • デンマーク
  • エストニア
  • フィンランド
  • フランス
  • ドイツ
  • ギリシャ
  • 香港
  • ハンガリー
  • アイスランド
  • インド
  • インドネシア
  • イラン
  • イラク
  • アイルランド
  • イスラエル
  • イタリア
  • 日本
  • ヨルダン
  • クウェート
  • ラトビア
  • レバノン
  • リトアニア
  • マレーシア
  • マルタ
  • メキシコ
  • ミャンマー
  • オランダ
  • ニュージーランド
  • ノルウェー
  • オマーン
  • パキスタン
  • ペルー
  • フィリピン
  • ポーランド
  • ポルトガル
  • カタール
  • ルーマニア
  • サウジアラビア
  • セルビア
  • シンガポール
  • スロバキア
  • スロベニア
  • 韓国
  • スペイン
  • スウェーデン
  • スイス
  • 台湾
  • タイ
  • 英国
  • アラブ首長国連邦
  • 米国
  • ベネズエラ
  • ベトナム

第9章 競合企業プロファイル

  • Abbott
  • AdnaGen/Alere
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • Diasorin
  • 栄研化学
  • Elitech Group
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • 富士レビオ
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech/Leica
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • タカラバイオ
  • Targeted Diagnostics & Therapeutics
  • 東ソー
  • Thermo
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

第10章 付録:がん診断技術・応用を開発している主な大学・研究機関

目次
Product Code: VP41887

This new 75-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.

The report provides granular market segmentation analysis and forecasts for over 40 tumor markers; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current and emerging assays; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and growth strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Regions

Asia-Pacific, Europe, Latin America, Middle East, North America

Country Analyses

Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Ghana, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Morocco, Myanmar, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, UK, United Arab Emirates, USA, Venezuela, Vietnam

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Tests

- Oncogenes - Biochemical Markers - Growth Factors - Colony Stimulating Factors - Hormones - Immunohistochemical Stains - Lymphokines

- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers in major countries by individual test.

- Five-year test volume and sales forecasts for major cancer diagnostic assays.

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

- Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Danaher Becton Dickinson bioMerieux Bio-Rad CellSearch Cepheid Clinical Genomics Decode Genetics DiaSorin Diazyme Eiken Chemical Elitech Group Enzo Biochem Epigenomics Exact Sciences Fujirebio Guided Therapeutics Hologic Janssen Diagnostics Leica Biosystems Kyowa Medex Myriad Genetics OncoLab Ortho-Clinical Diagnostics Panacea Pharmaceuticals PerkinElmer Polymedco Qiagen Quest Diagnostics Roche Scienion Sequenom Siemens Healthineers Takara Bio Theradiag Thermo Fisher Tosoh Vermillion Wako Pure Chemicals

Contains 1,450 pages and 582 tables

Table of Contents

I. Introduction

II. Worldwide Market Overview

III. Major Product Development Opportunities

  • A. Reagent Kits and Test Systems/Panels
  • B. Instrumentation
  • C. Computers, Software and Automation
  • D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies

VI. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VII. Worldwide Market and Technology Overview

  • A. Cancer Statistics and Etiology
    • 1. Breast Cancer
    • 2. Lung Cancer
    • 3. Colon and Rectum Cancer
    • 4. Prostate Cancer
    • 5. Stomach Cancer
    • 6. Leukemia
    • 7. Lymphoma
    • 8. Oral Cancer
    • 9. Skin Cancer
    • 10. Uterine Cancer
    • 11. Ovarian Cancer
    • 12. Bladder Cancer
  • B. Major Current and Emerging Cancer Diagnostic Tests
    • 1. Introduction
    • 2. Tumor Marker Classification
    • 3. ACTH
    • 4. Alpha-Fetoprotein (AFP)
    • 5. Beta-2 Microglobulin
    • 6. CA 15-3/27.29
    • 7. CA 19-9
    • 8. CA-125
    • 9. Calcitonin
    • 10. Carcinoembrionic Antigen (CEA)
    • 11. Estrogen and Progesterone Receptors
    • 12. Ferritin
    • 13. Gastrin
    • 14. Human Chorionic Gonadotropin (HCG)
    • 15. Insulin
    • 16. NSE
    • 17. Occult Blood
    • 18. PAP Smear/HPV
    • 19. Prostatic Acid Phosphatase (PAP)
    • 20. Prostate-Specific Antigen (PSA)
    • 21. Squamous Cell Carcinoma Antigen (SCC)
    • 22. T and B Lymphocytes
    • 23. TdT
    • 24. Thyroglobulin
    • 25. Tissue Polypeptide Antigen (TPA)
    • 26. Biochemical Tumor Markers
    • 27. Oncogenes
      • Abl/abl-bcr
      • AIB1
      • BCL-2
      • BRCA1
      • CD44
      • C-fos
      • C-myb
      • C-myc
      • CYP-17
      • Erb-B
      • HPC1
      • N-myc
      • P40
      • P51
      • P53
      • PIK3CA
      • PTI-1
      • Ras
      • Reg
      • Sis
      • Src
    • 28. Polypeptide Growth Factors
      • Basic Fibroblast Growth Factor
      • Beta-TGF
      • Cachectin (TNT)
      • Calmodulin
      • ECFR
      • Nerve Growth Factor (NGF)
      • Epidermal Growth Factor (EGF)
      • Ornithine Decarboxylase
      • Transferrin
      • Transforming Growth Factor-Alpha
    • 29. Ectopic Hormones
    • 30. Colony Stimulating Factors
    • 31. Lymphokines
      • Alpha-Interferon
      • B Cell Growth Factors
      • B Cell Growth Factor (BCGF)
      • Gamma-Interferon
      • Interleukin-1 (IL-1)
      • Macrophage Activating Factor
    • 32. Immunohistochemical Stains
    • 33. Emerging Tumor Markers
      • N-Acetylglucosamine
      • Actin
      • Alpha-Actin
      • Antineuronal Antibodies
      • 7B2
      • B72.3
      • Bax
      • BCD-F9
      • BLCA-4
      • Blood Group Antigens A,B,H
      • CA 50
      • CA 72-4/TAG-72
      • CA 195
      • CA-242
      • CA-549
      • CAM 26
      • CAR-3
      • Cathepsin-D
      • Chromogranin A and B
      • Cluster 1 Antigen
      • Cluster-5/5A Antigen
      • CTA
      • CU18
      • DR-70
      • DU-PAN-2
      • Endometrial Bleeding Associated Factor
      • Endostatin
      • Epithelial Membrane Antigen
      • Feulgen Hydrolysis
      • Fibronectin
      • FSH
      • (1->3)-L-fucosyltransferase
      • Gastrin-Releasing Peptide (GRP)
      • GDCFP-15
      • Glucagon
      • Glycoamines
      • H23
      • Her-2
      • Human Carcinoma Antigen
      • HPA
      • HSP27
      • Intermediate Filaments
      • Cytokeratins/CK18/Cyfra 21-1
      • Desmin
      • Gliofibrillary Acid Protein
      • Neurofilaments
      • Vimentin
      • KA 93
      • Kinases
      • KP16D3
      • LAI
      • Leukocyte Common Antigen
      • Lewis Antigens
      • Lysophosphatidic Acid (LPA)
      • Ma 695/Ma 552
      • MABDF3
      • MAG
      • ME1
      • Minactivin
      • MN/CA9
      • MSA
      • Mucin Cancer Antigen (MCA)
      • Multiple Tumor Suppressor 1
      • Myosin
      • NEA-130
      • NMP22
      • OA-519
      • Opioid Peptides
      • P-glycoprotein
      • Pancreatic Oncofetal Antigen (POA)
      • Placental Lactogen
      • PR92
      • Proliferative Index, Ki-67
      • Px
      • RB Inactivation/Deletion
      • Ret
      • SCCL 175
      • Selectin
      • Sialic Acid
      • Sialyl SSEA-1/SLX
      • SN10
      • Somatostatin
      • TA-90
      • TABA
      • Tachykinin
      • TAG 12
      • TPS
      • Troponin
      • Tubulin
      • VCAM
      • VEGF
      • Villen
  • C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
  • D. Current and Emerging Cancer Diagnostic Technologies
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
    • 3. Molecular Diagnostics
    • 4. Chromosome Analysis
      • a. Chronic Myelogenous Leukemia (CML)
      • b. Acute Myeloid Leukemia (AML)
      • c. Acute Lymphoblastic Leukemia (ALL)
      • d. Malignant Lymphomas Lymphoid Malignancies
      • e. Chronic Lymphocytic Leukemia (CLL)
      • f. Solid Cancers
      • g. Chromosomal Translocation and Oncogenes
    • 5. Artificial Intelligence
    • 6. Flow Cytometry
    • 7. Two Dimensional Gel Electrophoresis (2-DGE)
    • 8. Biosensors
    • 9. Competing/Complementing Technologies
  • E. Personal Testing

VIII. Country Market Analyses: Test Volume and Sales Forecasts, Supplier Shares

  • Argentina
  • Australia
  • Austria
  • Bahrain
  • Bangladesh
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Egypt
  • Estonia
  • Finland
  • France
  • Germany
  • Ghana
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kenya
  • Kuwait
  • Latvia
  • Lebanon
  • Lithuania
  • Malaysia
  • Malta
  • Mexico
  • Morocco
  • Myanmar
  • Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • UK
  • United Arab Emirates
  • USA
  • Venezuela
  • Vietnam

IX. Competitive Profiles

  • Abbott
  • AdnaGen/Alere
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Elitech Group
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech/Leica
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Thermo
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

X. Appendix: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

List of Tables

  • Argentina Cancer Diagnostic Volume Forecasts by Test
  • Argentina Cancer Diagnostics Sales Forecasts by Test
  • Australia Cancer Diagnostic Volume Forecasts by Test
  • Australia Cancer Diagnostics Sales Forecasts by Test
  • Austria Cancer Diagnostic Volume Forecasts by Test
  • Austria Cancer Diagnostics Sales Forecasts by Test
  • Bahrain Cancer Diagnostic Volume Forecasts by Test
  • Bahrain Cancer Diagnostics Sales Forecasts by Test
  • Bangladesh Cancer Diagnostic Volume Forecasts by Test
  • Bangladesh Cancer Diagnostics Sales Forecasts by Test
  • Belgium Cancer Diagnostic Volume Forecasts by Test
  • Belgium Cancer Diagnostics Sales Forecasts by Test
  • Brazil Cancer Diagnostic Volume Forecasts by Test
  • Brazil Cancer Diagnostics Sales Forecasts by Test
  • Bulgaria Cancer Diagnostic Volume Forecasts by Test
  • Bulgaria Cancer Diagnostics Sales Forecasts by Test
  • Canada Cancer Diagnostic Volume Forecasts by Test
  • Canada Cancer Diagnostics Sales Forecasts by Test
  • Chile Cancer Diagnostic Volume Forecasts by Test
  • Chile Cancer Diagnostics Sales Forecasts by Test
  • China Cancer Diagnostic Volume Forecasts by Test
  • China Cancer Diagnostics Sales Forecasts by Test
  • Colombia Cancer Diagnostic Volume Forecasts by Test
  • Colombia Cancer Diagnostics Sales Forecasts by Test
  • Croatia Cancer Diagnostic Volume Forecasts by Test
  • Croatia Cancer Diagnostics Sales Forecasts by Test
  • Cyprus Cancer Diagnostic Volume Forecasts by Test
  • Cyprus Cancer Diagnostics Sales Forecasts by Test
  • Czech Republic Cancer Diagnostic Volume Forecasts by Test
  • Czech Republic Cancer Diagnostics Sales Forecasts by Test
  • Denmark Cancer Diagnostic Volume Forecasts by Test
  • Denmark Cancer Diagnostics Sales Forecasts by Test
  • Egypt Cancer Diagnostic Volume Forecasts by Test
  • Egypt Cancer Diagnostics Sales Forecasts by Test
  • Estonia Cancer Diagnostic Volume Forecasts by Test
  • Estonia Cancer Diagnostics Sales Forecasts by Test
  • Finland Cancer Diagnostic Volume Forecasts by Test
  • Finland Cancer Diagnostics Sales Forecasts by Test
  • France Executive Summary Table: Total Cancer
  • Diagnostic Test Volume and Sales Forecast by Market Segment
  • France, Estimated Cancer Death Rates Per 100,000 Population
  • France, Laboratories Performing Tumor Marker Tests by Market Segment
  • France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • France, Total Tumor Marker Test Volume Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Test Volume Forecast
  • France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • France, Commercial/Private Laboratories Marker Test Volume Forecast
  • France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Sales Forecast by Test
  • France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
  • France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
  • France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
  • France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Total Tumor Marker Sales by Major Suppliers
  • France, AFP Testing Market Diagnostics Sales by Major Supplier
  • France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • France, CEA Testing Market Diagnostics Sales by Major Supplier
  • France, NSE Testing Market Diagnostics Sales by Major Supplier
  • France, PAP Testing Market Diagnostics Sales by Major Supplier
  • France, PSA Testing Market Diagnostics Sales by Major Supplier
  • Germany Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Germany, Estimated Cancer Death Rates Per 100,000 Population
  • Germany, Laboratories Performing Tumor Marker Tests by Market Segment
  • Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Germany, Total Tumor Marker Test Volume Forecast by Market Segment
  • Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
  • Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • Germany, Total Tumor Marker Sales Forecast by Market Segment
  • Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Calcitonin Test Volume and Diagnostic Sales Forecast by Market Segment
  • Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Total Tumor Marker Sales by Major Supplier
  • Germany, AFP Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CEA Testing Market Diagnostics Sales by Major Supplier
  • Germany, PSA Testing Market Diagnostics Sales by Major Supplier
  • Ghana Cancer Diagnostic Volume Forecasts by Test
  • Ghana Cancer Diagnostics Sales Forecasts by Test
  • Greece Cancer Diagnostic Volume Forecasts by Test
  • Greece Cancer Diagnostics Sales Forecasts by Test
  • Hong Kong Cancer Diagnostic Volume Forecasts by Test
  • Hong Kong Cancer Diagnostics Sales Forecasts by Test
  • Hungary Cancer Diagnostic Volume Forecasts by Test
  • Hungary Cancer Diagnostics Sales Forecasts by Test
  • Iceland Cancer Diagnostic Volume Forecasts by Test
  • Iceland Cancer Diagnostics Sales Forecasts by Test
  • India Cancer Diagnostic Volume Forecasts by Test
  • India Cancer Diagnostics Sales Forecasts by Test
  • Indonesia Cancer Diagnostic Volume Forecasts by Test
  • Indonesia Cancer Diagnostics Sales Forecasts by Test
  • Iran Cancer Diagnostic Volume Forecasts by Test
  • Iran Cancer Diagnostics Sales Forecasts by Test
  • Iraq Cancer Diagnostic Volume Forecasts by Test
  • Iraq Cancer Diagnostics Sales Forecasts by Test
  • Ireland Cancer Diagnostic Volume Forecasts by Test
  • Ireland Cancer Diagnostics Sales Forecasts by Test
  • Israel Cancer Diagnostic Volume Forecasts by Test
  • Israel Cancer Diagnostics Sales Forecasts by Test
  • Italy Executive Summary Table: Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estimated Cancer Death Rates Per 100,000 Population
  • Italy, Laboratories Performing Tumor Marker Tests by Market Segment
  • Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Italy, Total Tumor Marker Test Volume Forecast by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
  • Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Total Tumor Marker Test Market Forecast by Market Segment
  • Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
  • Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Colon Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Total Tumor Markers Sales by Major Suppliers
  • Italy, AFP Testing Market Diagnostics Sales by Major Supplier
  • Italy, CEA Testing Market Diagnostics Sales by Major Supplier
  • Italy, PSA Testing Market Diagnostics Sales by Major Supplier
  • Japan Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Japan, Estimated Cancer Death Rates Per 100,000 Population
  • Japan, Laboratories Performing Tumor Marker Tests by Market Segment
  • Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Japan, Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
  • Japan, Total Tumor Marker Testing Volume Forecast by Market Segment
  • Japan, All Market Segments Major Tumor Marker Test Volume Forecast
  • Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Japan, Total Tumor Marker Sales Forecast by Market Segment
  • Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Total Tumor Marker Sales by Major Suppliers
  • Japan, AFP Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
  • Japan, PAP Testing Market Diagnostics Sales by Major Supplier
  • Japan, PSA Testing Market Diagnostics Sales by Major Supplier
  • Jordan Cancer Diagnostic Volume Forecasts by Test
  • Jordan Cancer Diagnostics Sales Forecasts by Test
  • Kenya Cancer Diagnostic Volume Forecasts by Test
  • Kenya Cancer Diagnostics Sales Forecasts by Test
  • Kuwait Cancer Diagnostic Volume Forecasts by Test
  • Kuwait Cancer Diagnostics Sales Forecasts by Test
  • Latvia Cancer Diagnostic Volume Forecasts by Test
  • Latvia Cancer Diagnostics Sales Forecasts by Test
  • Lebanon Cancer Diagnostic Volume Forecasts by Test
  • Lebanon Cancer Diagnostics Sales Forecasts by Test
  • Lithuania Cancer Diagnostic Volume Forecasts by Test
  • Lithuania Cancer Diagnostics Sales Forecasts by Test
  • Malaysia Cancer Diagnostic Volume Forecasts by Test
  • Malaysia Cancer Diagnostics Sales Forecasts by Test
  • Malta Cancer Diagnostic Volume Forecasts by Test
  • Malta Cancer Diagnostics Sales Forecasts by Test
  • Mexico Cancer Diagnostic Volume Forecasts by Test
  • Mexico Cancer Diagnostics Sales Forecasts by Test
  • Morocco Cancer Diagnostic Volume Forecasts by Test
  • Morocco Cancer Diagnostics Sales Forecasts by Test
  • Myanmar Cancer Diagnostic Volume Forecasts by Test
  • Myanmar Cancer Diagnostics Sales Forecasts by Test
  • Netherlands Cancer Diagnostic Volume Forecasts by Test
  • Netherlands Cancer Diagnostics Sales Forecasts by Test
  • New Zealand Cancer Diagnostic Volume Forecasts by Test
  • New Zealand Cancer Diagnostics Sales Forecasts by Test
  • Nigeria Cancer Diagnostic Volume Forecasts by Test
  • Nigeria Cancer Diagnostics Sales Forecasts by Test
  • Norway Cancer Diagnostic Volume Forecasts by Test
  • Norway Cancer Diagnostics Sales Forecasts by Test
  • Oman Cancer Diagnostic Volume Forecasts by Test
  • Oman Cancer Diagnostics Sales Forecasts by Test
  • Pakistan Cancer Diagnostic Volume Forecasts by Test
  • Pakistan Cancer Diagnostics Sales Forecasts by Test
  • Peru Cancer Diagnostic Volume Forecasts by Test
  • Peru Cancer Diagnostics Sales Forecasts by Test
  • Philippines Cancer Diagnostic Volume Forecasts by Test
  • Philippines Cancer Diagnostic Volume Forecasts by Test
  • Poland Cancer Diagnostics Sales Forecasts by Test
  • Poland Cancer Diagnostic Volume Forecasts by Test
  • PortugalCancer Diagnostics Sales Forecasts by Test
  • Portugal Cancer Diagnostic Volume Forecasts by Test
  • Qatar Cancer Diagnostic Volume Forecasts by Test
  • Qatar Cancer Diagnostics Sales Forecasts by Test
  • Romania Cancer Diagnostic Volume Forecasts by Test
  • Romania Cancer Diagnostics Sales Forecasts by Test
  • Saudi Arabia Cancer Diagnostic Volume Forecasts by Test
  • Saudi Arabia Cancer Diagnostics Sales Forecasts by Test
  • Serbia Cancer Diagnostic Volume Forecasts by Test
  • Serbia Cancer Diagnostics Sales Forecasts by Test
  • Singapore Cancer Diagnostic Volume Forecasts by Test
  • Singapore Cancer Diagnostics Sales Forecasts by Test
  • Slovakia Cancer Diagnostic Volume Forecasts by Test
  • Slovakia Cancer Diagnostics Sales Forecasts by Test
  • Slovenia Cancer Diagnostic Volume Forecasts by Test
  • Slovenia Cancer Diagnostics Sales Forecasts by Test
  • South Africa Cancer Diagnostic Volume Forecasts by Test
  • South Africa Cancer Diagnostics Sales Forecasts by Test
  • South Korea Cancer Diagnostic Volume Forecasts by Test
  • South Korea Cancer Diagnostics Sales Forecasts by Test
  • Spain Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Spain, Estimated Cancer Death Rates Per 100,000 Population
  • Spain, Laboratories Performing Tumor Marker Tests by Market Segment
  • Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Spain, Total Tumor Marker Test Volume Forecast by Market Segment
  • Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
  • Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Spain, Total Tumor Marker Sales Forecast by Market Segment
  • Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Total Tumor Marker Sales by Major Suppliers
  • Spain, AFP Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CEA Testing Market Diagnostics Sales by Major Supplier
  • Spain, PSA Testing Market Diagnostics Sales by Major Supplier
  • Sweden Cancer Diagnostic Volume Forecasts by Test
  • Sweden Cancer Diagnostics Sales Forecasts by Test
  • Switzerland Cancer Diagnostic Volume Forecasts by Test
  • Switzerland Cancer Diagnostics Sales Forecasts by Test
  • Taiwan Cancer Diagnostic Volume Forecasts by Test
  • Taiwan Cancer Diagnostics Sales Forecasts by Test
  • Thailand Cancer Diagnostic Volume Forecasts by Test
  • Thailand Cancer Diagnostics Sales Forecasts by Test
  • U.K. Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • U.K., Estimated Cancer Death Rates Per 100,000 Population
  • U.K., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
  • U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.K., Total Tumor Marker Sales Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
  • U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Colon-Specific Antigen Test Volume and Diagnostics Sales by Market Segment
  • U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Total Tumor Marker Sales and Market Shares Forecast
  • U.K., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.K., PSA Testing Market Diagnostics Sales by Major Supplier
  • United Arab Emirates Cancer Diagnostic Volume Forecasts by Test
  • United Arab Emirates Cancer Diagnostics Sales Forecasts by Test
  • U.S.A. Executive Summary Table: Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • U.S.A., Estimated New Cancer Cases and Deaths
  • U.S.A., Estimated Cancer Death Rates Per 100,000 Population
  • U.S.A., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.S.A., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.S.A., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
  • U.S.A., Physician Office Laboratories Performing Tumor Marker Tests by Practice Size
  • U.S.A., Total Tumor Marker Test Volume Forecast by Market Segment
  • U.S.A., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.S.A., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.S.A., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • U.S.A., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
  • U.S.A., Total Tumor Marker Sales Forecast by Market Segment
  • U.S.A., All Market Segment Major Tumor Marker Sales Forecast by Test
  • U.S.A., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.S.A., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • U.S.A., Cancer Clinics Major Tumor Marker Sales Forecast by Test
  • U.S.A., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., CEA Test Volume and Diagnostics Sales by Market Segment
  • U.S.A., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Colon-specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Total Tumor Marker Sales by Major Supplier
  • U.S.A., ACTH Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., AFP Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., CA 125 Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Ferritin Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., HCG Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Insulin Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., PAP Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
  • U.S.A., PSA Testing Market Diagnostics Sales by Major Supplier
  • Venezuela Cancer Diagnostic Volume Forecasts by Test
  • Venezuela Cancer Diagnostics Sales Forecasts by Test
  • Vietnam Cancer Diagnostic Volume Forecasts by Test
  • Vietnam Cancer Diagnostics Sales Forecasts by Test
  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing
  • Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications in Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis